Fas (Apo-1/CD95) – Ligand expression on neoplastic plasma cells and its role for the expansion of the neoplastic clone.

Fridrik MA, Greil R, Hausmaninger H, Krieger O, Oppitz P, Stöger M, Klocker J, Neubauer M, Helm W, Pont J, Fazeny B, Hudec M, Simonitsch I, Radaszkiewicz T. Ann Hematol. 1997 Oct,75(4):135-40.

Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillance.

Villunger A, Egle A, Marschitz I, Kos M, Böck G, Ludwig H, Geley S, Kofler R, Greil R. Blood. 1997 Jul 1,90(1):12-20.

Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells.

Villunger A, Egle A, Kos M, Hartmann BL, Geley S, Kofler R, Greil R. Cancer Res. 1997 Aug 15,57(16):3331-4.

Interferon-alpha-2C and LD ara-C for the treatment of patients with CML: results of the Austrian multi-center phase II study.

Thaler J, Hilbe W, Apfelbeck U, Linkesch W, Sill H, Seewann H, Pont J, Bernhart M, Stöger M, Niessner H, Abbrederis K, Geissler D, Hausmaninger H, Lin W, Ludwig H, Lang A, Duba C, Fluckinger T, Greil R, Grünewald K, Konwalinka G, Niederwieser D, et al. Leuk Res. 1997 Jan,21(1):75-80.

Cytokine priming of the granulocyte respiratory burst in myelodysplastic syndromes.

Zabernigg A, Hilbe W, Eisterer W, Greil R, Ludescher C, Thaler J. Leuk Lymphoma. 1997 Sep,27(1-2):137-43.

The interleukin 1beta-converting enzyme inhibitor CrmA prevents Apo1/Fas- but not glucocorticoid-induced poly(ADP-ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cells.

Geley S, Hartmann BL, Kapelari K, Egle A, Villunger A, Heidacher D, Greil R, Auer B, Kofler R. FEBS Lett. 1997 Jan 27,402(1):36-40.

Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin’s lymphoma: dose finding and identification of predictors of response.

Cazzola M, Messinger D, Battistel V, Bron D, Cimino R, Enller-Ziegler L, Essers U, Greil R, Grossi A, Jäger G, LeMevel A, Najman A, Silingardi V, Spriano M, van Hoof A, Ehmer B. Blood. 1995 Dec 15,86(12):4446-53.

2′,2′-Difluorodeoxycytidine (gemcitabine) induces apoptosis in myeloma cell lines resistant to steroids and 2-chlorodeoxyadenosine (2-CdA).

Gruber J, Geisen F, Sgonc R, Egle A, Villunger A, Boeck G, Konwalinka G, Greil R. Stem Cells. 1996 May,14(3):351-62.

Necrotizing vasculitis associated with hepatitis C virus infection: successful treatment of vasculitis with interferon-alpha despite persistence of mixed cryoglobulinemia.

Sepp NT, Umlauft F, Illersperger B, GrГјnewald K, Schuler G, Greil R, Vogel W. Dermatology. 1995,191(1):43-5.

Gastric malt lymphoma with crystalline immunoglobulin inclusions and secondary immunoblastic lymphoma in a cervical lymph node.

Fend F, Gabl C, Hittmair A, Greil R, Feichtinger H. Pathol Res Pract. 1995 Oct,191(10):1053-8.